The hallmarks of mitochondrial dysfunction in chronic kidney disease.

[1]  P. Overbeek,et al.  Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy. , 2017, Kidney international.

[2]  O. Kretz,et al.  Targeting mTOR Signaling Can Prevent the Progression of FSGS. , 2017, Journal of the American Society of Nephrology : JASN.

[3]  J. Marine,et al.  Non‐coding RNAs: the dark side of nuclear–mitochondrial communication , 2017, The EMBO journal.

[4]  M. Hirschey,et al.  Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases , 2017, Nature Reviews Nephrology.

[5]  Joshua A. Bittker,et al.  Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes , 2017, Cell.

[6]  J. Rieusset,et al.  Metabolic signaling functions of ER-mitochondria contact sites: role in metabolic diseases. , 2017, Journal of molecular endocrinology.

[7]  R. Coward,et al.  Peroxisome proliferator activating receptor‐&ggr; and the podocyte , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  P. Overbeek,et al.  Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. , 2016, The Journal of clinical investigation.

[9]  Y. Nakatani,et al.  Epigenetic Regulation Through SIRT1 in Podocytes. , 2016, Current hypertension reviews.

[10]  A. Benigni,et al.  Clinical Practice : Mini-Review , 2016 .

[11]  D. Corcoran,et al.  miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy , 2016, Nature Communications.

[12]  M. Bhasin,et al.  PGC1α-dependent NAD biosynthesis links oxidative metabolism to renal protection , 2016, Nature.

[13]  P. Schumacker,et al.  Dynamin-Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects against Progression of Diabetic Nephropathy. , 2016, Journal of the American Society of Nephrology : JASN.

[14]  M. Cooper,et al.  miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. , 2015, Clinical science.

[15]  K. Tuttle,et al.  Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths , 2015, Diabetes Spectrum.

[16]  Y. Kanwar,et al.  Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. , 2015, Journal of the American Society of Nephrology : JASN.

[17]  Jian-Kang Chen,et al.  EGF receptor deletion in podocytes attenuates diabetic nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[18]  G. Remuzzi,et al.  Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. , 2015, Journal of Clinical Investigation.

[19]  Kumar Sharma,et al.  Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.

[20]  Shawn S Badal,et al.  MicroRNAs and their applications in kidney diseases , 2015, Pediatric Nephrology.

[21]  L. MacMillan-Crow,et al.  Targeting mitochondrial oxidants may facilitate recovery of renal function during infant sepsis , 2014, Clinical pharmacology and therapeutics.

[22]  Prashant Mishra,et al.  Mitochondrial dynamics and inheritance during cell division, development and disease , 2014, Nature Reviews Molecular Cell Biology.

[23]  Zhonghan Li,et al.  Therapeutic targeting of microRNAs: current status and future challenges , 2014, Nature Reviews Drug Discovery.

[24]  B. Viollet,et al.  AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. , 2013, The Journal of clinical investigation.

[25]  L. Guarente,et al.  Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes , 2013, Nature Medicine.

[26]  M. Ciriolo,et al.  Punctum on two different transcription factors regulated by PGC-1α: nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2. , 2013, Biochimica et biophysica acta.

[27]  H. Nagasu,et al.  Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status. , 2013, Kidney international.

[28]  Xiao-ming Meng,et al.  miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes , 2013, Diabetologia.

[29]  Ping Zhang,et al.  Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. , 2012, Kidney international.

[30]  W. Hsu,et al.  Transgenic Control of Mitochondrial Fission Induces Mitochondrial Uncoupling and Relieves Diabetic Oxidative Stress , 2012, Diabetes.

[31]  P. Overbeek,et al.  Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. , 2012, Cell metabolism.

[32]  J. Long,et al.  Identification of MicroRNA-93 as a Novel Regulator of Vascular Endothelial Growth Factor in Hyperglycemic Conditions* , 2010, The Journal of Biological Chemistry.

[33]  C. Cohen,et al.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. , 2010, The Journal of clinical investigation.

[34]  Z. Dong,et al.  Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. , 2009, The Journal of clinical investigation.

[35]  A. Nairn,et al.  CaM kinase Iα–induced phosphorylation of Drp1 regulates mitochondrial morphology , 2008, The Journal of cell biology.

[36]  R. Scarpulla.  Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.

[37]  S. Strack,et al.  Reversible phosphorylation of Drp1 by cyclic AMP‐dependent protein kinase and calcineurin regulates mitochondrial fission and cell death , 2007, EMBO reports.

[38]  C. Blackstone,et al.  Cyclic AMP-dependent Protein Kinase Phosphorylation of Drp1 Regulates Its GTPase Activity and Mitochondrial Morphology* , 2007, Journal of Biological Chemistry.

[39]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[40]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[41]  W. Guder,et al.  Renal substrate metabolism. , 1986, Physiological reviews.